Emin Hematol, 2003; 40(2): 1075 5. Tsurumi T, Fujita M, Kudoh A: Latent and lytic Epstein-Barr virus replication methods. Rev Med Virol, 2005; 15(1): 35 6. Kieff E, Rickinson AB: Epstein-Barr virus and its replication. In: Knipe DM, Howley PM, Griffin DE et al. (eds.), Fields virology. 5th ed. voll II. Philadelphia: Lippincott Williams Milkins; 2007; 26034 7. Speck P, Haan KM, Longnecker R: Epstein-Barr virus entry into cells. Virology, 2000; 277: 1 8. Hadinoto V, Shapiro M, Greenough TC et al: Around the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood, 2008; 111: 14207 9. Odumade OA, Hogquist KA, Balfour HH Jr: Progress and Complications in Understanding and Managing Principal Epstein-Barr Virus Infections. Clin Microbiol Rev, 2011; 24: 19309 10. Eligio P, Delia R, Valeria G: EBV Chronic Infections. Medit J Hemat Infect Dis, 2010; two(1): 19 11. Vetsika EK, Callan M: Infectious mononucleosis and Epstein-Barr virus. Specialist Rev Mol Med, 2004; six: 16 12. Sauce D, Larsen M, Curnow SJ et al: EBV-associated mononucleosis results in long-term worldwide deficit in T-cell responsiveness to IL-15. Blood, 2006; 108: 118 13. Thacker EL, Mirzaei F, Ascherio A: Infectious mononucleosis and danger for a number of sclerosis: a meta-analysis. Ann Neurol, 2006; 59: 49903 14. James JA, Harley JB, Scofield RH: Epstein-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol, 2006; 18: 4627 15. Harley JB, Harley IT, Guthridge JM, James JA: The curiously suspicious: a function for Epstein-Barr virus in lupus. Lupus, 2006; 15: 7687 16. Rouse BT, Horohov DW: Immunosuppression in viral infections. Rev Infect Dis, 1986; 8: 8503 17.Eugenol Groux HG, Torpier D, Monte Y et al: Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic people.Trastuzumab emtansine (solution) J Exp Med, 1992; 175: 3310 18. Nystad TW, Myrmel H: Prevalence of key versus reactivated Epstein-Barr virus infection in individuals with VCA IgG-, VCA IgM and EBNA-1-antibodies and suspected infectious mononucleosis.PMID:24834360 J Clin Virol, 2007; 38: 2927 19. Klutts JS, Ford BA, Perez NR, Gronowski AM: Proof based method for interpretation of Epstein-Barr virus serological patterns. J Clin Microbiol, 2009; 47: 32040 20. Taga K, Taga H, Tosato G: Diagnosis of atypical circumstances of infectious mononucleosis. Clin Infect Dis, 2001; 33: 838 21. Polidori MC, Mecocci P, Levine M, Frei B: Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. Arch Biochem Biophys, 2004; 423: 1095 22. Karanth S, Yu WH, Walczewska A et al: Ascorbic acid acts as an inhibitory transmitter in the hypothalamus to inhibit stimulated luteinizing hormone-releasing hormone release by scavenging nitric oxide. PNAS, 2000; 97(four): 18916 23. Rice ME, Russo-Menna I: Differential compartmentalization of brain ascorbate and glutathione among neurons and glia. Neuroscience, 1998; 82(4): 12133 24. Hickey S, Saul AW: Vitamin C: The Real Story, the Exceptional and Controversial Healing Element. Anderson J, editor. Laguna Beach (CA): Beasic Overall health Publications, 2008 25. Klenner FR: The significance of high each day intake of ascorbic acid in preventive medicine. In: Williams R, Kalita DK (eds.), Physician’s Handbook on Orthomolecular Medicine. 3rd ed. New York: Pergamon Press, 1979; 519 26. Webb AL, Villamor E: Update: Effects of antioxidant and non-antioxidant vitamin supplementation on immune function. Nutrition Critiques,.
